← Eichor
Study identifier: NCT06614790 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.

Condition: Ovarian Cancer  ·  Sponsor: Pomeranian Medical University Szczecin

PhaseN/A
Planned participants300
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The study is observational, not interventional. The study will include patients with advanced ovarian cancer who have been treated in Poland based on a previous early access program, and who are currently being treated under the B.50 drug program, funded by the National Health Fund. Only patients currently being treated in the B.50 program at 10 selected centers listed on this site may be included in the study. Of course, any patient in Poland eligible for maintenance treatment with niraparib can receive the drug, regardless of participation in this RWE study.The treatment involves administering niraparib as maintenance therapy for 3 years after the completion of chemotherapy, provided that the patient has responded to systemic treatment (NED, CR, PR).

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (12)

Oddział Onkologii Ginekologicznej Białostockiego Centrum OnkologiiBialystok, PolandRecruiting
Klinika Położnictwa i Ginekologii, Ginekologii Onkologicznej Uniwersyteckie Centrum KliniczneGdansk, PolandNot Yet Recruiting
III Klinika Radioterapii i Chemioterapii Narodowego Instytutu Onkologicznego w GliwicachGliwice, PolandNot Yet Recruiting
Świętokrzyskie Centrum OnkologiiKielce, PolandNot Yet Recruiting
Klinika Ginekologii Onkologicznej Narodowego Instytutu Onkologicznego w KrakowieKrakow, PolandNot Yet Recruiting
I Katedra i Klinika Ginekologii Onkologicznej i Ginekologii Uniwersytetu Medycznego w LublinieLublin, PolandNot Yet Recruiting
Opolskie Centrum OnkologiiOpole, PolandNot Yet Recruiting
Oddział Onkologii Klinicznej i Radioterapii, Siedleckie Centrum OnkologiiSiedlce, PolandNot Yet Recruiting
Klinika Ginekologii Operacyjnej i Onkologii Ginekologicznej Dorosłych i Dziewcząt PUMSzczecin, PolandNot Yet Recruiting
Klinika Ginekologii Operacyjnej i Onkologii Ginekologicznej Dorosłych i Dziewcząt PUMSzczecin, PolandNot Yet Recruiting
, Klinika Ginekologii Onkologicznej, Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie w WarszawieWarsaw, PolandNot Yet Recruiting
Klinika Ginekologii Onkologicznej, Centrum Onkologii-Instytut im. Marii Skłodowskiej-Curie w WarszawieWarsaw, PolandNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06614790